Combivent and Kenalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivent (albuterol sulfate; ipratropium bromide) and Kenalog (triamcinolone acetonide). Common drug interactions include dizziness among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Combivent and Kenalog. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.



On Jul, 28, 2026

64 people who take Combivent and Kenalog together, and have interactions are studied.

Combivent and Kenalog drug interactions.

What are the common drug interactions of Combivent and Kenalog, by gender? *:

female:

  1. Dizziness
  2. Hypertension (high blood pressure)
  3. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  4. Mass
  5. Sinusitis (inflammation of sinus)
  6. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  7. Tuberculin test positive
  8. Uterine cancer
  9. Blood cholesterol increased
  10. Cardiomegaly (increased size of heart than normal)

male:

  1. Cardiac failure congestive
  2. Dyspnoea (difficult or laboured respiration)
  3. Cough
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Diastolic dysfunction
  6. Disease progression
  7. Dizziness
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypoxia (low oxygen in tissues)

What are the common drug interactions of Combivent and Kenalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Cardiac failure congestive
  3. Cholecystitis (infection of gallbladder)
  4. Influenza like illness
  5. Insomnia (sleeplessness)
  6. Urinary tract infection
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  9. Mass
  10. Presyncope

30-39:

n/a

40-49:

  1. Drug dependence
  2. Dyspnoea (difficult or laboured respiration)
  3. Sleep disorder
  4. Wheezing (a high-pitched whistling sound made while you breath)

50-59:

  1. Insomnia (sleeplessness)
  2. Mania (a state of abnormally elevated or irritable mood)
  3. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  4. Oedema peripheral (superficial swelling)
  5. Pneumonia streptococcal (pneumonia, caused by streptococcus pneumoniae)
  6. Post-traumatic stress disorder
  7. Rash
  8. Sleep terror (felling of terror in sleep)
  9. Suicidal ideation
  10. Weight increased

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Injury
  5. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  6. Vomiting
  7. Anal sphincter atony (anal muscles are weak and cannot ensure an efficient sealing, this is called a sphincter atony)
  8. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  9. Anxiety
  10. Aphasia (damage to the parts of the brain that control language)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 7 people, 10.94%
  2. High Blood Pressure: 6 people, 9.38%
  3. Dyspnea (difficult or laboured breathing): 6 people, 9.38%
  4. Rashes (redness): 5 people, 7.81%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 6.25%
  6. Migraine (headache): 4 people, 6.25%
  7. Itching: 4 people, 6.25%
  8. Hypersensitivity: 4 people, 6.25%
  9. High Blood Cholesterol: 4 people, 6.25%
  10. Depression: 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Combivent and Kenalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Combivent and Kenalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kenalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kenalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide and triamcinolone acetonide (the active ingredients of Combivent and Kenalog, respectively), and Combivent and Kenalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: